Oncology News Articles

▼ Show details

The latest Cancer and Oncology news articles published daily by MDLinx physician editors who comb through the top peer-reviewed clinical journals for the medical articles that will make a difference to you and your practice. Organized by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants can stay current on latest oncology topics, symptoms, treatments, risk factors in Cancer and Hematology.

New! >> Start your free Oncology Board Exam Prep course now.
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

1 Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): A randomised, multicentre, open-label, phase 3 non-inferiority trial The Lancet Oncology, October 30, 2014    Clinical Article

2 A phase III trial of high-dose interferon alfa-2b versus cisplatin, vinblastine, and dacarbazine DTIC, plus interleukin-2 and interferon in patients with high-risk melanoma—an intergroup study of cancer and leukemia group B, Children’s Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group Journal of Clinical Oncology, October 30, 2014    Clinical Article

3 Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: An open-label, phase 2 trial The Lancet Oncology, October 30, 2014    Clinical Article

4 Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells International Journal of Cancer, October 30, 2014    Clinical Article

5 Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: Study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel Cancer Chemotherapy and Pharmacology, October 30, 2014    Clinical Article

6 A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer Clinical and Translational Oncology, October 30, 2014    Clinical Article

7 A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults Full Text Current Oncology, October 30, 2014    Clinical Article

8 Active cigarette smoking and risk of breast cancer International Journal of Cancer, October 30, 2014    Clinical Article

9 High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia Clinical and Translational Oncology, October 30, 2014    Clinical Article

10 High S100A8 and S100A12 protein expression is a favorable prognostic factor for survival of oropharyngeal squamous cell carcinoma International Journal of Cancer, October 30, 2014    Clinical Article

11 Impact of reirradiation of painful osseous metastases on quality of life and function: A secondary analysis of the NCIC CTG SC.20 randomized trial Journal of Clinical Oncology, October 30, 2014    Clinical Article

12 Meaningful patient representation informing Canada's cancer drug funding decisions: views of patient representatives on the Pan-Canadian Oncology Drug Review Full Text Current Oncology, October 30, 2014    Clinical Article

13 Resampling the N9741 trial to compare tumor dynamic versus conventional end points in randomized phase II trials Journal of Clinical Oncology, October 30, 2014    Clinical Article

14 Increased expression of chitinase 3-like 1 is a prognosis marker for non-small cell lung cancer correlated with tumor angiogenesis Tumor Biology, October 30, 2014    Clinical Article

15 Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumors Cancer Chemotherapy and Pharmacology, October 30, 2014    Clinical Article

16 A MDM2-dependent positive-feedback loop is involved in inhibition of miR-375 and miR-106b induced by Helicobacter pylori lipopolysaccharide International Journal of Cancer, October 30, 2014    Clinical Article

17 Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity International Journal of Cancer, October 30, 2014    Clinical Article

18 Genes involved in the WNT and vesicular trafficking pathways are associated with melanoma predisposition International Journal of Cancer, October 30, 2014    Clinical Article

19 Fascin1 in carcinomas: Its regulation and prognostic value International Journal of Cancer, October 30, 2014    Review Article

20 Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients International Journal of Cancer, October 30, 2014    Clinical Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last

Clinical Pearls in Oncology

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Highlights in Oncology

Immunophenotype of small intestinal adenocarcinoma predicts survival

As reported in the European Journal of Obstetrics and Gynecology & Reproductive Biology, levels of the adipokine, apelin, are decreased in women with PCOS (n=45) compared to healthy controls. Apelin levels are positively correlated with BMI, insulin levels, triglycerides levels, free testosterone levels, the Ferriman-Gallwey score, and the HOMA index. Apelin levels are negatively correlated with HDL levels.

Increased incidence of second primary cancers in patients with salivary gland tumors

As reported in JAMA—Otolaryngology-Head & Neck Surgery, patients with salivary gland tumors have an increased risk of second primary tumors and newly developed cancers. Specifically, the cumulative 2-, 5-, and 10-year rates for second primary cancers are 4.4%, 8.3%, and 12.4%, respectively. Similarly, the cumulative 2-, 5-, and 10-year rates for newly diagnosed cancers are 1.1%, 3.4%, and 10.5%, respectively.

VPAC1 overexpression associated with colon cancer aggression

As reported in Tumor Biology, VPAC1 expression is increased in poorly differentiated compared to well-differentiated colon cancer. VPAC1 expression is also increased in the blood vessels and macrophages adjacent to colon cancer tissues compared to healthy tissues. The overexpression of VPAC1 is related to EGFR overexpression.


Other Topics in Oncology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close